HDL Cholesterol 2003--Fourth Annual International Conference.  Metabolic pathways and drug targets.  2-4 March 2003, Cambridge, MA, USA.
Meng
Charles Q
CQ
AtheroGenics Inc., 8995 Westside Parkway, Alpharetta, GA 30004, USA. cmeng@atherogenics.com
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004032:Diet; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008660:Metabolism / Q000187:drug effects*; D010316:Particle Size
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008074:Lipoproteins